Kalaris Therapeutics, Inc. · NASDAQ:KLRS
EcoR1 Capital, LLC's stake in Kalaris Therapeutics, Inc. fell to 1.10% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
EcoR1 Capital, LLC's stake in Kalaris Therapeutics, Inc. fell to 1.10%, 201,718 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 1.10%
- Shares
- 201,718
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 1.10% | 201,718 |
| Oleg Nodelman | 1.10% | 201,718 |
| EcoR1 Capital Fund Qualified, L.P. | 1.00% | 191,242 |
Source
Related
- Kalaris Therapeutics, Inc.
- EcoR1 Capital, LLC
- Kalaris Therapeutics, Inc. shareholders
- Form 4 · Srinivas Akkaraju · May 22, 2026
- Schedule 13D/A · Akkaraju Srinivas · May 22, 2026
- Schedule 13G · Rtw Investments, LP · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 22, 2025